Aspirin
31
8
9
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 31 trials
100.0%
+13.5% vs benchmark
39%
12 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (31)
Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)
Low Dose Aspirin Alerts in High-Risk Pregnancies
Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II
Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
Immunomodulation During Pregnancy
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial
The Effect of Aspirin on Recurrent Acute Pancreatitis
Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg
INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURE
The Prevention of Thromboembolic Complications Associated With Coil Embolization
GM03 - Platelet RNA Signatures of Aspirin
When Should Low-dose Aspirin be Resumed After Peptic Ulcer Bleeding?
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Protective Effect of Aspirin on COVID-19 Patients
Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin
Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack